Protein Aggregation Inhibitors as Disease-Modifying Therapies for Polyglutamine DiseasesEiko N. Minakawa, Yoshitaka Nagai|Frontiers in Neuroscience|2021Cited by 52
Arginine is a disease modifier for polyQ disease models that stabilizes polyQ protein conformationEiko N. Minakawa, Yoshitaka Nagai|Brain|2020Cited by 38